Rolando Morales Espinosa
Recently, in April 2020, it was approved by the FDA (Food and Drugs Administration of the United States), the beginning of clinical tests for the detection of infection by the virus "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2)” through saliva samples in health centers that have an agreement with Rutgers University, the institution that designed the test. Historically, saliva samples have been successfully used for diagnostic purposes in the detection of other viral infections such as Human Papillomavirus (HPV), Hepatitis (A-E) and Human Immunodeficiency (HIV). It is a test that is easily applicable, inexpensive, less invasive with the patient and practically does not require exposure of medical personnel to patients suspected of infection, so it constitutes a valid diagnostic alternative in the emergency circumstances that it is challenging health systems in the world.
KEY WORDS: saliva, coronavirus, SARS-CoV-2.
How to cite this article
MORALES, E. R. La saliva como biomuestra para diagnóstico de infección por SARS-CoV-2: Una revisión. Int. J. Odontostomat., 14(3):327-330, 2020.